rosiglitazone has been researched along with Left Ventricular Hypertrophy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AbdelGawad, H; Baraka, A | 1 |
| Kaur, T; Pal Singh, A; Singh Bedi, PM; Singh, N; SinghDahiya, R | 1 |
| Fernandes, G; Halade, GV; Lindsey, ML; Williams, PJ | 1 |
| Bu, PL; Hao, MX; Hou, XY; Li, CB; Liu, JN; Ti, Y; Wang, ZH; Zhang, W; Zhang, Y; Zhao, XQ | 1 |
| de Roos, A; Dehnavi, RA; Lamb, HJ; Mertens, BJ; Roes, SD; Tamsma, JT; Westenberg, JJ | 1 |
| De Champlain, J; Wang, R; Wilson, TW; Wu, L | 1 |
| Laverty, R; Ledingham, JM | 1 |
| Hansmann, G; Perez, VA; Rabinovitch, M; Schellong, S; Sheikh, AY; Stewart, DJ; Suen, RS; Urashima, T; Wagner, RA; Wang, L | 1 |
1 trial(s) available for rosiglitazone and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Effect of lifestyle intervention plus rosiglitazone or placebo therapy on left ventricular mass assessed with cardiovascular magnetic resonance in the metabolic syndrome.
Topics: Aged; Combined Modality Therapy; Diet; Double-Blind Method; Exercise; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Linear Models; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Middle Aged; Netherlands; Predictive Value of Tests; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome; Ventricular Remodeling | 2011 |
7 other study(ies) available for rosiglitazone and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Targeting apoptosis in the heart of streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; Fenofibrate; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Male; Myocytes, Cardiac; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rosiglitazone; Streptozocin; Thiazolidinediones | 2010 |
Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Methionine; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice.
Topics: Aging; Animals; Collagen; Corn Oil; Diet; Female; Fish Oils; Heart; Hyperglycemia; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Inflammation; Insulin Resistance; Mice; Mice, Inbred C57BL; Rosiglitazone; Thiazolidinediones; Ultrasonography | 2011 |
Rosiglitazone attenuates myocardial remodeling in spontaneously hypertensive rats.
Topics: Animals; Collagen Type I; Collagen Type III; Hypertension; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Male; Matrix Metalloproteinase 9; NF-kappa B; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Treatment Outcome; Ultrasonography; Up-Regulation; Ventricular Remodeling | 2011 |
Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Myocardium; Organ Size; Peroxisome Proliferators; PPAR alpha; PPAR gamma; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rosiglitazone; Tachycardia; Thiazolidinediones; Weight Gain | 2004 |
Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Basilar Artery; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Mesenteric Arteries; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Wistar; Rosiglitazone; Simvastatin; Tetrazoles; Thiazolidinediones; Tunica Media; Valine; Valsartan | 2005 |
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.
Topics: Adiponectin; Animals; Apolipoproteins E; Becaplermin; Cell Proliferation; Cells, Cultured; Diet; Disease Models, Animal; Female; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-sis; Risk Factors; Rosiglitazone; Sex Factors; Thiazolidinediones | 2007 |